MWM
IHE icon

Meridian Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Meridian Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,812
Closed -$910 – 325
2019
Q2 		$910 Buy
+1,812
New +$89.6K 0.04% 287

Other funds holding IHE

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RCYC
Richard C. Young & Co Newport, Rhode Island $1.21B AUM 38.41% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Meridian Wealth Management's IHE Position: Q3 2019 in Review

Meridian Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2019, closing a stake of 1,812 shares — an estimated $910 sold.

Meridian Wealth Management first reported a position in IHE in Q2 2019 and held it in 1 quarter. The position peaked at $910 in Q2 2019. 82 funds tracked by Wall St. Rank hold IHE as of Q3 2019.

  • Meridian Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
  • Meridian Wealth Management sold 1,812 iShares US Pharmaceuticals ETF shares in Q3 2019, an estimated $910.
  • Meridian Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2019 and held it in 1 quarter.
  • Meridian Wealth Management's iShares US Pharmaceuticals ETF position peaked at $910 in Q2 2019.
  • 82 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2019.

Based on Meridian Wealth Management's 13F filing for Q3 2019, filed 8 Nov 2019.